Omkar Pharmachem share news and announcements

BSE: 532167Chemicals & PetrochemicalsSmall Cap

₹7.23₹0.36 (4.74%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹7.59.

52-week range of traded prices to 23 Oct 2026

₹7.08Low, 15 Sep 2026₹29.74High, 15 Dec 2025

Under BSE's graded surveillance, stage II, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.

Market cap: ₹7.29 Cr3,900th largest listed
P/E: 85.6
P/B: 0.2
Dividend yield: Nonein the last 12 months
ROE: 0.4%
ROCE: 0.3%
Debt to equity: 0.00
Volume, BSE: 100

Omkar Pharmachem share news and announcements

405 announcements, routine notices left out, newest first. Page 2 of 9.

Nov 2024
- 5 Nov · Board meeting
  OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve OMKAR PHARMACHEM LTD. has .... (opens in a new tab)
Oct 2024
- 1 Oct · Meeting
  Voting Results of 29th AGM of the Company in terms of Reg. 44(3) of SEBI (LODR) Regulations 2015 along with Consolidated Scrutinizer Report. (opens in a new tab)
Sep 2024
Aug 2024
- 12 Aug · Board meeting
  Omkar Pharmachem Limited informed the BSE that the meeting of the Board of Directors of the Company is scheduled on 12.08.2024, inter alia, to consider, approve and take on record the Unaudited .... (opens in a new tab)
- 12 Aug · Board meeting
  Outcome of the board meeting held on 12th August 2024 for approval of Unaudited financial results for Quarter ended on June 2024 (opens in a new tab)
- 5 Aug · Board meeting
  Meeting on 12 Aug 2024: quarterly results
- 3 Aug · Board meeting
  OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 ,inter alia, to consider and approve OMKAR PHARMACHEM LTD. has .... (opens in a new tab)
Jul 2024
- 15 Jul · Management
  Dear Sir, Pursuant to Regulation 30 and other applicable provisions of the Listing Regulations, We would like to bring to your kind notice that based on the recommendation of the nomination .... (opens in a new tab)
May 2024
- 30 May · Management
  Dear Sir, Please find attached resignation intimation of Company secretary and Compliance officer. (opens in a new tab)
- 30 May · Results
  Dear Sir, Please find attached Audited Financial results for Quarter and year ended as on March 31, 2024 (opens in a new tab)
- 30 May · Board meeting
  Outcome of the board meeting held on 30th May 2024 for approval of Audited financial statements for Quarter and year ended on March 2024 (opens in a new tab)
- 22 May · Board meeting
  Meeting on 30 May 2024: audited results
- 22 May · Board meeting
  OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Audited Financial results .... (opens in a new tab)
Apr 2024
- 26 Apr · Compliances- Submission Of Certificate Under Regulation 40 (9) Of SEBI (LODR) Regulations, 2015
  Dear Sir, Please find enclosed herewith certificate issued by the practicing Company Secretary pursuant to Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) .... (opens in a new tab)
- 18 Apr · Compliances-Compliance Certificate For The March, 31 2024
  Compliance Certificate under regulation 7(3) of SEBI LODR (Listing Obligation and Disclosure requirements) Regulations, 2015 for the year ended 31st March 2024 (opens in a new tab)
Feb 2024
- 14 Feb · Results
  Approval of Unaudited Financial Results alongwith Limited Review Report for the Quarter and nine months ended on 31st December 2023 (opens in a new tab)
- 14 Feb · Board meeting
  Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held .... (opens in a new tab)
- 6 Feb · Board meeting
  Meeting on 14 Feb 2024: quarterly results
- 6 Feb · Board meeting
  OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve the Unaudited Financial .... (opens in a new tab)
Dec 2023
- 23 Dec · Management
  Dear Sir, Pursuant to the provisions of Regulation 30 of SEBI (LODR), we wish to inform you that Mr. Arun Kumar has appointed as CFO and KMP of the company w.e.f 23rd December 2023 (opens in a new tab)
- 15 Dec · Management
  Disclosure under Regulation 30 of LODR w.r.t Resignation of Chief Financial Officer of the company i.e. Mr. Amit Jain. (opens in a new tab)
Nov 2023
- 10 Nov · Results
  Dear Sir, Please find Unaudited financial results for quarter and half year ended 30th September 2023 (opens in a new tab)
- 10 Nov · Board meeting
  Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held .... (opens in a new tab)
- 2 Nov · Board meeting
  Meeting on 10 Nov 2023: quarterly results
- 2 Nov · Board meeting
  OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 ,inter alia, to consider and approve Unaudited financial results .... (opens in a new tab)
Sep 2023
Aug 2023
- 29 Aug · Board meeting
  Outcome of the Board Meeting held on 29th August, 2023 (opens in a new tab)
- 14 Aug · Results
  Unaudited Financial Results for Quarter ended on June 2023 (opens in a new tab)
- 14 Aug · Results
  Unaudited Financial Results of the Company, for the Quarter ended on 30th June, 2023, alongwith Limited Review Report of the company. (opens in a new tab)
- 4 Aug · Board meeting
  Meeting on 14 Aug 2023: quarterly results
- 4 Aug · Board meeting
  OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve and take on record the Unaudited .... (opens in a new tab)
May 2023
- 30 May · Management
  Dear Sir, With reference to Captioned subject and pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please note that Mr. Amit Jain .... (opens in a new tab)
- 30 May · Results
  Dear Sir(s), Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please find enclosed herewith: 1.Audited .... (opens in a new tab)
- 30 May · Results
  Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held .... (opens in a new tab)
- 23 May · Board meeting
  Meeting on 30 May 2023: audited results
- 20 May · Board meeting
  OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve the Audited Financial Results .... (opens in a new tab)
Apr 2023
- 25 Apr · Compliances-Submission Of Certificate Under Regulation 40(9) Of The SEBI LODR
  Dear Sir, Please find enclosed herewith Certificate issued by the Practicing Company Secretary pursuant to regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) .... (opens in a new tab)
- 19 Apr · Compliances- Compliance Certificate For The Period Ended March 2023
  Compliance Certificate under Regulation 7(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 for the year ended 31st March 2023 (opens in a new tab)
Feb 2023
- 14 Feb · Results
  Dear Sir(s), Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please find enclosed herewith: Unaudited .... (opens in a new tab)